Skip to main content
. 2020 Mar 30;9(4):947. doi: 10.3390/jcm9040947

Figure 2.

Figure 2

GLP-1RA RCT studies with known beneficial cardiovascular endpoints. Blue bars—percentage of 3-point MACE reduction with the intervention drug. Orange bars—percentage of individual primary cardiovascular endpoint reduction with the intervention drug. Three-point MACE, 3-point MACE; MI, fatal and nonfatal myocardial infarction.